SILVERCREST ASSET MANAGEMENT GROUP LLC

Position in NVCR — NovoCure Ltd

CIK 1232395 NEW YORK, NY

Position in NVCR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$14,070,411

+$5,516,037 QoQ

Shares Held

928,740

+18.3% QoQ

Ownership

0.798%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#25

of 217 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 69% Shared 0% None 31%

Healthcare · as of Jun 30, 2026

SILVERCREST ASSET MANAGEMENT GROUP LLC holds $400,923,542 across 27 Medical Devices names. NVCR ranks #10 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	940,395	$85,331,442
2	SYK	Stryker Corp	182,236	$57,375,182
3	HAE	Haemonetics Corp	493,796	$37,034,700
4	ITGR	Integer Holdings Corp	371,484	$34,715,179
5	AORT	Artivion, Inc.	1,024,091	$23,011,324
6	BSX	Boston Scientific Corp	461,588	$19,700,575
7	SIBN	SI-BONE, Inc.	1,158,576	$18,907,960
8	GKOS	GLAUKOS Corp	121,880	$17,033,948

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,070,411	928,740	+18.3%	Shares	Sole	2026-08-14
2026-03-31	$8,554,374	784,805	+10.9%	Shares	Sole	2026-05-15
2025-12-31	$9,149,384	707,609	+0.2%	Shares	Sole	2026-02-17
2025-09-30	$9,122,489	706,075	+30.7%	Shares	Sole	2025-11-14
2025-06-30	$9,617,286	540,297	+18.0%	Shares	Sole	2025-08-14
2025-03-31	$8,162,058	458,028	+31.5%	Shares	Sole	2025-05-15
2024-12-31	$10,379,548	348,307	-29.8%	Shares	Sole	2025-02-14
2024-09-30	$7,754,214	496,111	+28.7%	Shares	Sole	2024-11-14
2024-06-30	$6,602,073	385,410	+27747.5%	Shares	Sole	2024-08-15
2020-12-31	$239,487	1,384	-56.4%	Shares	Sole	2021-02-16
2020-09-30	$352,964	3,171	—	Shares	Sole	2020-11-16
No filing history on record for this holder in this stock.